A phase III randomised, double-blind placebo controlled study to compare the effectiveness of oral Risperidone and oral Haloperidol in the management of delirium
| DOI | 10.58084/c81x-td25 |
| Type of DOI | Dataset |
| Publisher | Cancer Symptom Trials (CST) |
| Creator(s) | Meera Agar, Liverpool Hospital |
| Date made available | 2023 |
| Description of dataset | Dataset includes: Two hundred forty-seven participants were included in intention-to-treat analysis (82 receiving risperidone, 81 receiving haloperidol, and 84 receiving placebo. Treatment period over 72 hours |
| Funding | Australian Government |
| Subject (ANZSRC category) | Clinical sciences (pain) |
| ANZCTR reference | ACTRN12607000501448 |
| Main trial page | PaCCSC clinical trials |
| Publications | Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial |
| Dataset access | Access can be requested via the Health Data Australia catalogue. Search for the ACTRN number in the catalogue to find datasets associated with these trials or email enquiries to hesanda@uts.edu.au. |